Generic Drugs Market- By Drug Class & By Geography (Europe, Asia-Pacific, Others) - Forecast(2024 - 2030)

Report Code: HCR 0217 Report Format: PDF + Excel
Generic Drugs Market Size is forecast to reach $ 471316 Million by 2030, at a CAGR of 5.50% during forecast period 2024-2030.A generic drug is an identical or bioequivalent copy of a branded drug. These drugs are chemically identical to their branded counterparts; but they are typically sold at substantial discounts from the branded price. These drug classes have exactly the same dosage, intended use, effects, side effects, route of administration, risks, safety, and strength as the original drug. The cost-effectiveness of generic drugs has given it a competitive advantage over branded drugs in the market and is expected to be the key growth driver for generic drugs in the near future.

This report identifies the generic drugs market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to generic drugs market.
 
Generic Drugs Market

Globally, North America dominates the market for generic drugs in 2015 with highest market share due to easy availability of such drugs in the region along with regulations over prescription of branded drugs by governing authorities in the region. North America was followed by Europe as the second largest regional market for generic drugs. However, Asia-Pacific is expected to be the fastest growing regional segment during the period of study due to increasing awareness about generic drugs in the region.

This report on generic drugs covers different type of generic drugs classes, and market size in various geographical regions.

  • On the basis of applications of generic drugs, this report also covers all the major generic drugs classes in curing major diseases, some of the major drug classes covered in this report are as follows: Cardiovascular Products, Anti-Infective Drugs, Anti-Arthritis Drugs, Central Nervous System Drugs, Anti-Cancer Drugs, Respiratory Products and Others
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for generic drugs in each of the region.

This report identifies all the major companies operating in the generic drugs market. Some of the major companies’ profiles in detail are as follows:

  • WATSON PHARMACEUTICALS, INC.
  • TEVA PHARMACEUTICAL INDUSTRIES, LTD.
  • SANDOZ INTERNATIONAL GMBH      
  • RANBAXY LABORATORIES, LTD.
  • PAR PHARMACEUTICAL, INC.

Key Market Players:

The Top 5 companies in Generic Drugs Market are:

  1. Novartis
  2. Bristol-Myers-Squibb
  3. Glaxo Smith Kline (gsk) 
  4. Eli Lilly
  5. Pfizer
     

For more Lifesciences and Healthcare related reports, please click here

1. Generic Drugs – Market Overview
2. Executive Summary
3. Generic Drugs Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Generic Drugs – Market Forces
   4.1. Drivers
      4.1.1. cost-effectiveness of generic drugs against branded drugs
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Generic Drugs Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Generic Drugs Market, By Drug Class
   6.1. Cardiovascular Products
   6.2. Anti-Infective Drugs
   6.3. Anti-Arthritis Drugs
   6.4. Central Nervous System Drugs
   6.5. Anti-Cancer Drugs
   6.6. Respiratory Products
   6.7. Others
7. Generic Drugs Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Generic Drugs – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
   9.1. WATSON PHARMACEUTICALS, INC.
   9.2. TEVA PHARMACEUTICAL INDUSTRIES, LTD.
   9.3. SANDOZ INTERNATIONAL GMBH      
   9.4. RANBAXY LABORATORIES, LTD.
   9.5. PAR PHARMACEUTICAL, INC.  
   9.6. MYLAN INC.     
   9.7. HOSPIRA, INC.  
   9.8. DR. REDDY’S LABORATORIES, LTD.     
   9.9. APOTEX INC. 
   9.10. ACTAVIS      
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer

List of Tables:

Table 1: Generic Drugs Market Overview 2023-2030
Table 2: Generic Drugs Market Leader Analysis 2023-2030 (US$)
Table 3: Generic Drugs Market Product Analysis 2023-2030 (US$)
Table 4: Generic Drugs Market End User Analysis 2023-2030 (US$)
Table 5: Generic Drugs Market Patent Analysis 2013-2023* (US$)
Table 6: Generic Drugs Market Financial Analysis 2023-2030 (US$)
Table 7: Generic Drugs Market Driver Analysis 2023-2030 (US$)
Table 8: Generic Drugs Market Challenges Analysis 2023-2030 (US$)
Table 9: Generic Drugs Market Constraint Analysis 2023-2030 (US$)
Table 10: Generic Drugs Market Supplier Bargaining Power Analysis 2023-2030 (US$)
Table 11: Generic Drugs Market Buyer Bargaining Power Analysis 2023-2030 (US$)
Table 12: Generic Drugs Market Threat of Substitutes Analysis 2023-2030 (US$)
Table 13: Generic Drugs Market Threat of New Entrants Analysis 2023-2030 (US$)
Table 14: Generic Drugs Market Degree of Competition Analysis 2023-2030 (US$)
Table 15: Generic Drugs Market Value Chain Analysis 2023-2030 (US$)
Table 16: Generic Drugs Market Pricing Analysis 2023-2030 (US$)
Table 17: Generic Drugs Market Opportunities Analysis 2023-2030 (US$)
Table 18: Generic Drugs Market Product Life Cycle Analysis 2023-2030 (US$)
Table 19: Generic Drugs Market Supplier Analysis 2023-2030 (US$)
Table 20: Generic Drugs Market Distributor Analysis 2023-2030 (US$)
Table 21: Generic Drugs Market Trend Analysis 2023-2030 (US$)
Table 22: Generic Drugs Market Size 2023 (US$)
Table 23: Generic Drugs Market Forecast Analysis 2023-2030 (US$)
Table 24: Generic Drugs Market Sales Forecast Analysis 2023-2030 (Units)
Table 25: Generic Drugs Market, Revenue & Volume, By Drug Class, 2023-2030 ($)
Table 26: Generic Drugs Market By Drug Class, Revenue & Volume, By Cardiovascular Products, 2023-2030 ($)
Table 27: Generic Drugs Market By Drug Class, Revenue & Volume, By Anti-Infective Drugs, 2023-2030 ($)
Table 28: Generic Drugs Market By Drug Class, Revenue & Volume, By Anti-Arthritis Drugs, 2023-2030 ($)
Table 29: Generic Drugs Market By Drug Class, Revenue & Volume, By Central Nervous System Drugs, 2023-2030 ($)
Table 30: Generic Drugs Market By Drug Class, Revenue & Volume, By Anti-Cancer Drugs, 2023-2030 ($)
Table 31: North America Generic Drugs Market, Revenue & Volume, By Drug Class, 2023-2030 ($)
Table 32: South america Generic Drugs Market, Revenue & Volume, By Drug Class, 2023-2030 ($)
Table 33: Europe Generic Drugs Market, Revenue & Volume, By Drug Class, 2023-2030 ($)
Table 34: APAC Generic Drugs Market, Revenue & Volume, By Drug Class, 2023-2030 ($)
Table 35: Middle East & Africa Generic Drugs Market, Revenue & Volume, By Drug Class, 2023-2030 ($)
Table 36: Russia Generic Drugs Market, Revenue & Volume, By Drug Class, 2023-2030 ($)
Table 37: Israel Generic Drugs Market, Revenue & Volume, By Drug Class, 2023-2030 ($)
Table 38: Top Companies 2023 (US$)Generic Drugs Market, Revenue & Volume
Table 39: Product Launch 2023-2030Generic Drugs Market, Revenue & Volume
Table 40: Mergers & Acquistions 2023-2030Generic Drugs Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Generic Drugs Market 2023-2030
Figure 2: Market Share Analysis for Generic Drugs Market 2023 (US$)
Figure 3: Product Comparison in Generic Drugs Market 2023-2030 (US$)
Figure 4: End User Profile for Generic Drugs Market 2023-2030 (US$)
Figure 5: Patent Application and Grant in Generic Drugs Market 2013-2023* (US$)
Figure 6: Top 5 Companies Financial Analysis in Generic Drugs Market 2023-2030 (US$)
Figure 7: Market Entry Strategy in Generic Drugs Market 2023-2030
Figure 8: Ecosystem Analysis in Generic Drugs Market 2023
Figure 9: Average Selling Price in Generic Drugs Market 2023-2030
Figure 10: Top Opportunites in Generic Drugs Market 2023-2030
Figure 11: Market Life Cycle Analysis in Generic Drugs Market
Figure 12: GlobalBy Drug ClassGeneric Drugs Market Revenue, 2023-2030 ($)
Figure 13: Global Generic Drugs Market - By Geography
Figure 14: Global Generic Drugs Market Value & Volume, By Geography, 2023-2030 ($) 
Figure 15: Global Generic Drugs Market CAGR, By Geography, 2023-2030 (%)
Figure 16: North America Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 17: US Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 18: US GDP and Population, 2023-2030 ($)
Figure 19: US GDP – Composition of 2023, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2023-2030 ($)
Figure 21: Canada Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 22: Canada GDP and Population, 2023-2030 ($)
Figure 23: Canada GDP – Composition of 2023, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2023-2030 ($)
Figure 25: Mexico Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 26: Mexico GDP and Population, 2023-2030 ($)
Figure 27: Mexico GDP – Composition of 2023, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2023-2030 ($)
Figure 29: South America Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 30: Brazil Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 31: Brazil GDP and Population, 2023-2030 ($)
Figure 32: Brazil GDP – Composition of 2023, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2023-2030 ($)
Figure 34: Venezuela Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 35: Venezuela GDP and Population, 2023-2030 ($)
Figure 36: Venezuela GDP – Composition of 2023, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2023-2030 ($)
Figure 38: Argentina Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 39: Argentina GDP and Population, 2023-2030 ($)
Figure 40: Argentina GDP – Composition of 2023, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2023-2030 ($)
Figure 42: Ecuador Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 43: Ecuador GDP and Population, 2023-2030 ($)
Figure 44: Ecuador GDP – Composition of 2023, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2023-2030 ($)
Figure 46: Peru Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 47: Peru GDP and Population, 2023-2030 ($)
Figure 48: Peru GDP – Composition of 2023, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2023-2030 ($)
Figure 50: Colombia Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 51: Colombia GDP and Population, 2023-2030 ($)
Figure 52: Colombia GDP – Composition of 2023, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2023-2030 ($)
Figure 54: Costa Rica Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 55: Costa Rica GDP and Population, 2023-2030 ($)
Figure 56: Costa Rica GDP – Composition of 2023, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2023-2030 ($)
Figure 58: Europe Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 59: U.K Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 60: U.K GDP and Population, 2023-2030 ($)
Figure 61: U.K GDP – Composition of 2023, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2023-2030 ($)
Figure 63: Germany Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 64: Germany GDP and Population, 2023-2030 ($)
Figure 65: Germany GDP – Composition of 2023, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2023-2030 ($)
Figure 67: Italy Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 68: Italy GDP and Population, 2023-2030 ($)
Figure 69: Italy GDP – Composition of 2023, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2023-2030 ($)
Figure 71: France Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 72: France GDP and Population, 2023-2030 ($)
Figure 73: France GDP – Composition of 2023, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2023-2030 ($)
Figure 75: Netherlands Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 76: Netherlands GDP and Population, 2023-2030 ($)
Figure 77: Netherlands GDP – Composition of 2023, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2023-2030 ($)
Figure 79: Belgium Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 80: Belgium GDP and Population, 2023-2030 ($)
Figure 81: Belgium GDP – Composition of 2023, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2023-2030 ($)
Figure 83: Spain Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 84: Spain GDP and Population, 2023-2030 ($)
Figure 85: Spain GDP – Composition of 2023, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2023-2030 ($)
Figure 87: Denmark Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 88: Denmark GDP and Population, 2023-2030 ($)
Figure 89: Denmark GDP – Composition of 2023, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2023-2030 ($)
Figure 91: APAC Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 92: China Generic Drugs Market Value & Volume, 2023-2030
Figure 93: China GDP and Population, 2023-2030 ($)
Figure 94: China GDP – Composition of 2023, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2023-2030 ($)Generic Drugs Market China Export and Import Value & Volume, 2023-2030 ($)
Figure 96: Australia Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 97: Australia GDP and Population, 2023-2030 ($)
Figure 98: Australia GDP – Composition of 2023, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2023-2030 ($)
Figure 100: South Korea Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 101: South Korea GDP and Population, 2023-2030 ($)
Figure 102: South Korea GDP – Composition of 2023, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2023-2030 ($)
Figure 104: India Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 105: India GDP and Population, 2023-2030 ($)
Figure 106: India GDP – Composition of 2023, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2023-2030 ($)
Figure 108: Taiwan Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 109: Taiwan GDP and Population, 2023-2030 ($)
Figure 110: Taiwan GDP – Composition of 2023, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2023-2030 ($)
Figure 112: Malaysia Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 113: Malaysia GDP and Population, 2023-2030 ($)
Figure 114: Malaysia GDP – Composition of 2023, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2023-2030 ($)
Figure 116: Hong Kong Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 117: Hong Kong GDP and Population, 2023-2030 ($)
Figure 118: Hong Kong GDP – Composition of 2023, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2023-2030 ($)
Figure 120: Middle East & Africa Generic Drugs Market Middle East & Africa 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 121: Russia Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 122: Russia GDP and Population, 2023-2030 ($)
Figure 123: Russia GDP – Composition of 2023, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2023-2030 ($)
Figure 125: Israel Generic Drugs Market Value & Volume, 2023-2030 ($)
Figure 126: Israel GDP and Population, 2023-2030 ($)
Figure 127: Israel GDP – Composition of 2023, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2023-2030 ($)
Figure 129: Entropy Share, By Strategies, 2023-2030* (%)Generic Drugs Market
Figure 130: Developments, 2023-2030*Generic Drugs Market
Figure 131: Company 1 Generic Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 132: Company 1 Generic Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 133: Company 1 Generic Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 134: Company 2 Generic Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 135: Company 2 Generic Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 136: Company 2 Generic Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 137: Company 3 Generic Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 138: Company 3 Generic Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 139: Company 3 Generic Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 140: Company 4 Generic Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 141: Company 4 Generic Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 142: Company 4 Generic Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 143: Company 5 Generic Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 144: Company 5 Generic Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 145: Company 5 Generic Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 146: Company 6 Generic Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 147: Company 6 Generic Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 148: Company 6 Generic Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 149: Company 7 Generic Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 150: Company 7 Generic Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 151: Company 7 Generic Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 152: Company 8 Generic Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 153: Company 8 Generic Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 154: Company 8 Generic Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 155: Company 9 Generic Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 156: Company 9 Generic Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 157: Company 9 Generic Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 158: Company 10 Generic Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 159: Company 10 Generic Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 160: Company 10 Generic Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 161: Company 11 Generic Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 162: Company 11 Generic Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 163: Company 11 Generic Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 164: Company 12 Generic Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 165: Company 12 Generic Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 166: Company 12 Generic Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 167: Company 13 Generic Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 168: Company 13 Generic Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 169: Company 13 Generic Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 170: Company 14 Generic Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 171: Company 14 Generic Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 172: Company 14 Generic Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 173: Company 15 Generic Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 174: Company 15 Generic Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 175: Company 15 Generic Drugs Market Net Sales Share, By Geography, 2023 (%